Litcius/Paper detail

Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients

Lorenzo Maria Canziani, Serena Trovati, Enrico Brunetta, Amidio Testa, Maria De Santis, Emilio Bombardieri, Giacomo Maria Guidelli, Giovanni Albano, Marco Folci, Michela Squadroni, Giordano Beretta, Michele Ciccarelli, Massimo Castoldi, Ana Lleò, Alessio Aghemo, Laura Vernile, Alberto Malesci, Paolo Omodei, Claudio Angelini, Salvatore Badalamenti, Maurizio Cecconi, Alberto Cremonesi, Carlo Selmi

2020Journal of Autoimmunity91 citationsDOIOpen Access PDF

Topics & Concepts

TocilizumabMedicineInternal medicineHazard ratioClinical endpointConfidence intervalRetrospective cohort studyRandomized controlled trialRheumatoid arthritisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms